Samarendra N. Maiti
University of Alberta
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Samarendra N. Maiti.
Tetrahedron Letters | 1986
Samarendra N. Maiti; Maya P. Singh; Ronald G. Micetich
Les azides sont reduits en amines primaires par reaction avec le chlorure stanneux dans le methanol
Synthetic Communications | 1988
Samarendra N. Maiti; Paul Spevak; Maya P. Singh; Ronald G. Micetich; A. V. Narender Reddy
Abstract An efficient method for the reductive cleavage of symmetrical disulfides with hydrazines is described.
Synthetic Communications | 1988
Samarendra N. Maiti; Paul Spevak; A. V. Narender Reddy
Abstract A mild and facile method for the reduction of alkyl and aryl azides to the corresponding amines using alkaline earth metals is described.
Heterocycles | 2006
Ruppa P. Kamalesh Babu; Samarendra N. Maiti
Neuropsychiatric disorders have been actively studied for several decades. Many of these disorders were treated by pharmacotherapy, certain forms of psychotherapy, and electroconvulsive therapy. Several classes of drugs with a range of binding selectivities have been discovered and used in the treatment of various central nervous system (CNS) disorders. The earlier drugs had undesired side effects because of their binding to a broad range of neurotransmitters. However, with the advancement of science, there is an increasing understanding of the role of monoamine neurotransmitters in various CNS disorders, which had resulted in the rational design of potent drugs with very selective binding properties. Yet, there are many unanswered questions, and the CNS research is being more actively pursued than ever with newer additional tools such as magnetic resonance imaging (MRI), molecular imaging by positron emission tomography (PET), single-photon emission tomography (SPECT), etc. The goal of this review is to bring together the recent discoveries on selective norepinephrine reuptake inhibitors, developments, and their uses in depression and ADHD. Some of the dual inhibitors of norepinephrine and serotonin transporters have also been included in this review, as these have very similar applications.
Bioorganic & Medicinal Chemistry Letters | 2010
Amy B. Dounay; Nancy Sue Barta; Brian M. Campbell; Corey Coleman; Elizabeth M. Collantes; Lynne Denny; Satavisha Dutta; David L. Gray; Dongfeng Hou; Rathna Iyer; Samarendra N. Maiti; Daniel F. Ortwine; Al Probert; Nancy C. Stratman; Rajendra Subedi; Tammy Whisman; Wenjian Xu; Kim Zoski
Preclinical studies suggest that compounds with dual norepinephrine reuptake inhibitor (NRI) and 5-HT(1A) partial agonist properties may provide an important new therapeutic approach to ADHD, depression, and anxiety. Reported herein is the discovery of a novel chemical series with a favorable NRI and 5-HT(1A) partial agonist pharmacological profile as well as excellent selectivity for the norepinephrine transporter over the dopamine transporter.
Bioorganic & Medicinal Chemistry Letters | 1997
David P. Czajkowski; Andhe V. Narender Reddy; Eduardo L. Setti; Oludotun A. Phillips; Ronald G. Micetich; Chieko Kunugita; Samarendra N. Maiti
Abstract The synthesis and in vitro synergies of (6R)-6-(α-hydroxybenzyl)-2β-methoxyiminomethyl-2α-methylpenam-3α-carboxylate 1,1-dioxide ( 4 ) and 2β-acyl-2α-methylpenam-3α-carboxylate 1,1-dioxide ( 15 ) are described. Compound 15 showed good in vitro synergy in combination with piperacillin and ceftazidime against chromosomally mediated class I cephalosporinase producing organisms including TEM, SHV, and OXA-type enzymes producing microorganisms.
Bioorganic & Medicinal Chemistry Letters | 1996
Samarendra N. Maiti; David P. Czajkowski; Narender A. V. Reddy; Paul Spevak; Jadwiga Kaleta; Ronald G. Micetich
Abstract Treatment of 3-methyl-3-cephem sulphone with sodium hydride followed by carbon disulphide and alkyl halide provides an entry to 2-(1,3-diothiolan-2-ylidene)-cephem derivatives, which are new potent inhibitors of HSE.
Synthetic Communications | 1989
A. V. Narender Reddy; Samarendra N. Maiti; Inder Pal Singh; Ronald G. Micetich
Abstract Reaction of chlorosulfonyl isocyanate with nitroketene aminals of imidazolidines afforded acyclic intermediates which on treatment with diisopropylamine were smoothly transformed into the corresponding 1-substituted-1,2,3,7-tetrahydro-8-nitroimidazo [1,2-a] [1,2,6] thiadiazine-7 (1H) one-5, 5-dioxides.
Heterocycles | 1991
Samarendra N. Maiti; Paul Spevak; Rebecca Wong; Narender A. V. Reddy; Ronald G. Micetich; Kazuo Ogawa
A series of 2,2-bis(monosubstituted) methylpenicillin sulfones were prepared from 6,6-dibromopenicillanate by a double sulfoxide rearrangement. β-Lactamase inhibitory activity of 2,2-bis(chloromethyl)penicillanic acid sulfone was studied and its activity was compared with YTR-830
Tetrahedron Letters | 1985
Ronald G. Micetich; Samarendra N. Maiti; Motoaki Tanaka; Tomio Yamazaki; Kazuo Ogawa
Abstract The thermolysis of trichloroethyl 6-phenoxyacetamido penicillanate sulfoxide and ethyl 2-mercaptoacetate in toluene gave the unsym-azetidinone disulfide(β,γ-isomer) in 65% yield. With added catalytic amounts of N,N-dimethylaniline the α,β-isomer was the major product (60%), along with a new β-lactam cleaved product, 8 (5–6%).